Moderna and Merck announced the successful outcome of their Phase 3 combined treatment trials involving a new cancer vaccine and Keytruda.
2 reports, 2 independent
Updated Sep 8
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Moderna and Merck announced the successful outcome of their Phase 3 combined treatment trials involving a new cancer vaccine and Keytruda.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Moderna combined its vaccine with Merck's Keytruda drug.
- Moderna and Merck are developing a combination therapy using Keytruda.
- Moderna and Merrill jointly developed skin cancer vaccine trials.
- Moderna, Merck, and the National Cancer Institute announced successful trial results for a combined cancer vaccine and immunotherapy program.